← Browse by Condition
Medical Condition
substance use
Total Trials
8
Recruiting Now
8
Trial Phases
Phase 2
ClinicalMetric tracks all active clinical trials for substance use sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — substance use Clinical Trials
How many clinical trials are currently recruiting for substance use?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for substance use, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for substance use?
substance use research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a substance use clinical trial?
Eligibility criteria for substance use trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 1
Top Sponsors
2 trials
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06003725
Recruiting
Cultural Adaptation of Drug Treatment for DJJ Youth
Enrollment
55 pts
Location
United States
Sponsor
University of California, San ...
NCT06307977
Recruiting
Couples Motivational Interviewing to Reduce Drug Use and HIV Risk in Vulnerable Male Couples
Enrollment
360 pts
Location
United States
Sponsor
Hunter College of City Univers...
NCT05486234
Recruiting
CARS: Cannabis and Alcohol Reduction Study
Enrollment
52 pts
Location
United States
Sponsor
Medical University of South Ca...
NCT05260047
Recruiting
Culturally Responsive Community Driven Substance Use Recovery for Black and Latinx Population
Enrollment
525 pts
Location
United States
Sponsor
Yale University
NCT07075081 Phase 2
Recruiting
Gii'Igoshimong: Sitting With Your First Family
Enrollment
300 pts
Location
United States
Sponsor
Johns Hopkins Bloomberg School...
NCT06977178
Recruiting
Adverse Adolescent Pathways to Substance Use
Enrollment
180 pts
Location
United States
Sponsor
University of North Carolina, ...
NCT06489899
Recruiting
Peer Education for Gender Inclusion and Substance Use in Southern Africa
Enrollment
264 pts
Location
South Africa, Zambia...
Sponsor
University Hospital, Basel, Sw...
NCT06526143
Recruiting
M2VA Pain Care Pathway
Enrollment
1,800 pts
Location
United States
Sponsor
Yale University
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology